Companies

Allergan, Inc.

NYSE: AGN
$193.02
â–² $0.03 (+0.02%) today
Markets closed · 2:36am ET

AGN Coverage

Page 8
12:00pm ET
Investing

9 Big Stocks That Doubled in 2014

Here is a look at the top performers for 2014, nine stocks that have doubled and have a current market cap of at least $5 billion.

Paul Ausick
8:30am ET
Health and Healthcare

3 Likely Biotech Buyout Candidates

A new research report from the analysts at Cowen sees a potential wave of biotech deals, some of which could be of the blockbuster variety.

Lee Jackson
9:45am ET
Health and Healthcare

Allergan Chops 1,500 Jobs to Fend Off Valeant

Allergan reported better-than-expected second-quarter 2014 results before markets opened Monday morning. The Botox-maker also announced that it will execute a restructuring in the second half of 2014.

AGN
Paul Ausick
8:30am ET
Health and Healthcare

Valeant Offer Weaker After Allergan Earnings

In a sharply worded press release Monday morning, Valeant Pharmaceuticals said that it "can no longer tolerate" statements from Allergan that are "attempts to mislead investors."

Paul Ausick
5:44pm ET
Investing

John Paulson Talks Up Valeant and Allergan, and Merger Arb

ThinkstockHedge fund manager John Paulson spoke at the CNBC Institutional Investor Delivering Alpha conference on Wednesday, offering keen insight in the current merger environment. Paulson signaled that Valeant Pharmaceuticals International Inc. (NYSE:…

Jon C. Ogg